Page last updated: 2024-10-18

dihydroxyphenylalanine and Peritoneal Carcinomatosis

dihydroxyphenylalanine has been researched along with Peritoneal Carcinomatosis in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"We report the case of a carcinoid tumor with suspicion of recurrence on biology."1.36[Recurrent carcinoid tumor and 18F-DOPA PET]. ( Cavet, M; Dousset, B; Faraggi, M; Hignette, C; Modis, C; Richard, B; Tenenbaum, F, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavet, M1
Tenenbaum, F1
Hignette, C1
Modis, C1
Richard, B1
Faraggi, M1
Dousset, B1

Other Studies

1 other study available for dihydroxyphenylalanine and Peritoneal Carcinomatosis

ArticleYear
[Recurrent carcinoid tumor and 18F-DOPA PET].
    Gastroenterologie clinique et biologique, 2010, Volume: 34, Issue:3

    Topics: Biomarkers, Tumor; Carcinoid Tumor; Colonic Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotope

2010